Annual Drug Patent Expirations for CIALIS
Cialis is a drug marketed by Lilly and is included in one NDA. It is available from seven suppliers. There is one patent protecting this drug and two Paragraph IV challenges.
Drug patent litigation for CIALIS.
The generic ingredient in CIALIS is tadalafil. Seven suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
